These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

888 related items for PubMed ID: 33948116

  • 1. Ripretinib for the treatment of advanced gastrointestinal stromal tumor.
    Zalcberg JR.
    Therap Adv Gastroenterol; 2021; 14():17562848211008177. PubMed ID: 33948116
    [Abstract] [Full Text] [Related]

  • 2. The INSIGHT study: a randomized, Phase III study of ripretinib versus sunitinib for advanced gastrointestinal stromal tumor with KIT exon 11 + 17/18 mutations.
    George S, Blay JY, Chi P, Jones RL, Serrano C, Somaiah N, Gelderblom H, Zalcberg JR, Reichmann W, Sprott K, Cox P, Sherman ML, Ruiz-Soto R, Heinrich MC, Bauer S.
    Future Oncol; 2024; 20(27):1973-1982. PubMed ID: 39229786
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Early and Next-Generation KIT/PDGFRA Kinase Inhibitors and the Future of Treatment for Advanced Gastrointestinal Stromal Tumor.
    Bauer S, George S, von Mehren M, Heinrich MC.
    Front Oncol; 2021; 11():672500. PubMed ID: 34322383
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Ripretinib in patients with advanced gastrointestinal stromal tumours (INVICTUS): a double-blind, randomised, placebo-controlled, phase 3 trial.
    Blay JY, Serrano C, Heinrich MC, Zalcberg J, Bauer S, Gelderblom H, Schöffski P, Jones RL, Attia S, D'Amato G, Chi P, Reichardt P, Meade J, Shi K, Ruiz-Soto R, George S, von Mehren M.
    Lancet Oncol; 2020 Jul; 21(7):923-934. PubMed ID: 32511981
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Ripretinib for the treatment of advanced, imatinib-resistant gastrointestinal stromal tumors.
    Liu WZ, Du YQ, Shen Q, Tao KX, Zhang P.
    J Dig Dis; 2023 Sep 14. PubMed ID: 37706279
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Management of Patients With Advanced Gastrointestinal Stromal Tumor: Emphasis on Fourth-Line Treatment With Ripretinib.
    Brackert S, Polson K.
    J Adv Pract Oncol; 2023 May 14; 14(4):317-328. PubMed ID: 37313282
    [Abstract] [Full Text] [Related]

  • 14. Systemic Therapy for Gastrointestinal Stromal Tumor: Current Standards and Emerging Challenges.
    Huang WK, Wu CE, Wang SY, Chang CF, Chou WC, Chen JS, Yeh CN.
    Curr Treat Options Oncol; 2022 Sep 14; 23(9):1303-1319. PubMed ID: 35976553
    [Abstract] [Full Text] [Related]

  • 15. Gastrointestinal Stromal Tumors: What Is the Best Sequence of TKIs?
    Senchak J, Ahr K, von Mehren M.
    Curr Treat Options Oncol; 2022 May 14; 23(5):749-761. PubMed ID: 35349049
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Current status of and future prospects for the treatment of unresectable or metastatic gastrointestinal stromal tumours.
    Naito Y, Nishida T, Doi T.
    Gastric Cancer; 2023 May 14; 26(3):339-351. PubMed ID: 36913072
    [Abstract] [Full Text] [Related]

  • 18. Ripretinib for the treatment of adult patients with advanced gastrointestinal stromal tumors.
    Sargsyan A, Kucharczyk MA, Jones RL, Constantinidou A.
    Expert Rev Gastroenterol Hepatol; 2023 Feb 14; 17(2):119-127. PubMed ID: 36644853
    [Abstract] [Full Text] [Related]

  • 19. Progression of the tumor in a patient with a gastrointestinal stromal tumor with the PDGFRA exon 12 mutation who received multiple surgeries and multiple lines of tyrosine kinase inhibitor therapies: a case report.
    An Z, Tan M, Xia Y, Li Y, Fan L, Zhao Q, Zhang Z, Tan B, Liu Y, Ma Z, Wang D, Zhao X.
    J Gastrointest Oncol; 2022 Oct 14; 13(5):2620-2625. PubMed ID: 36388657
    [Abstract] [Full Text] [Related]

  • 20. [Gastrointestinal stromal tumors (GIST)].
    Jaros D, Bozic B, Sebesta C.
    Wien Med Wochenschr; 2023 Jun 14; 173(9-10):201-205. PubMed ID: 36155864
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 45.